secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEOGENOMICS INC (NEO)
CIK:        0001077183
Form:       8-K
Filed at:   2021-07-07T23:59:59+00:00
Accession:  0001077183-21-000179
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

NeoGenomics appoints Cardoza as President & COO, Lab Ops; Wallar as President, Pharma Services
--------------------------------------------------------------------------------

- George A. Cardoza appointed President and COO, Lab Operations effective July 5, 2021; base salary $500k, bonus target 60%.
- Dr. Gina M. Wallar appointed President, Pharma Services effective July 5, 2021; base salary $370k, bonus target 50%.
- Cardoza awarded equity valued at $1M (7,584 restricted shares + option for 40,502 shares); Wallar awarded $250k equity.
- Both appointments are internal promotions; Cardoza previously CFO and President Pharma Services, Wallar previously SVP Sales.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1077183/000107718321000179/0001077183-21-000179-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1077183/000107718321000179/neo-20210705.htm
  HTML page:      https://secwatch.observer/filing/0001077183-21-000179

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer